Skip to content
Hot News

ChrysCapital to Acquire Stake in Linux Laboratories  

Sanofi Partners with Tricog Health to Advance AI-Powered Cardiac Diagnostics 

HRV Pharma to Invest ₹150 Crore to Expand Peptide and High-Potency API Capabilities

Novartis India to Acquire Pfizer’s Minipress Trademarks for ₹1,250 Crore 

The PharmaIndiaThe PharmaIndia
The PharmaIndia

Your Compass In Indian Pharma

  • News
  • Deals
  • Regulatory & Policy
  • Insights
  • Opinions
  • Events
  • Companies
  • Newsletter
Main Menu
  • News
  • Deals
  • Regulatory & Policy
  • Insights
  • Opinions
  • Events
  • Companies
  • Newsletter

Saurabh Chaubey

  • Deals
  • Opinions

The Rise of Pharma-Tech Collaborations in India

Latest Developments in Pharma-Tech Partnerships  The pharmaceutical industry is undergoing a technological transformation as companies increasingly integrate advanced digital tools into research,...

Saurabh Chaubey
July 2, 2026
Read More
  • Opinions
  • Regulatory & Policy

Regulatory Landscape in Indian Biopharma: Hurdles & Reforms 

Recent Regulatory Developments  India’s biopharmaceutical industry stands at an inflection point where its scientific capabilities and production scale are increasingly recognized globa...

Saurabh Chaubey
June 25, 2026
Read More
  • Insights

Top 10 Generic Pharma Companies of 2025 

Summary   The Top 10 Generic Pharmaceutical Companies of 2025 highlight the continued growth and resilience of the global generics industry, led by Sandoz, Sun Pharma, and Fosun Pharma....

Saurabh Chaubey
June 19, 2026
Read More
  • Deals
  • Opinions

Digital Therapeutics and Pharma Partnerships in India 

Latest Developments in Digital Therapeutics  The rapid convergence of healthcare and technology is reshaping how diseases are managed and treated. Among the most promising innovations in this spa...

Saurabh Chaubey
June 18, 2026
Read More
  • Opinions
  • Regulatory & Policy

Global Regulatory Scrutiny: USFDA Inspections and Compliance Trends

Latest Developments in USFDA Inspections  India plays a crucial role in the global pharmaceutical supply chain, supplying a large share of generic medicines to markets around the world. As Indian...

Saurabh Chaubey
June 11, 2026
Read More
  • Manufacturing
  • Opinions

India’s Rise in Cell and Gene Therapy Manufacturing 

Latest Developments in Cell and Gene Therapy Manufacturing  Cell and gene therapies are rapidly emerging as one of the most transformative areas in modern medicine. These advanced therapies aim t...

Saurabh Chaubey
June 4, 2026
Read More
  • Markets
  • Opinions

The Booming CDMO Ecosystem: India’s Advantage in Contract Development & Manufacturing 

In recent years, India’s pharmaceutical landscape has witnessed a significant transformation. Beyond being the “pharmacy of the world” for affordable medicines, India is emerging as a preferred global...

Saurabh Chaubey
May 28, 2026
Read More
  • Opinions

India’s Biopharma Export Story: How “Pharmacy of the World” Is Evolving 

Relevant Global and Market Data  India’s biopharmaceutical export story is one of remarkable transformation. From being a net importer of medicines in the late 20th century to becoming the “...

Saurabh Chaubey
May 21, 2026
Read More
  • Deals
  • Opinions

Startup Spotlight: Biotech Entrepreneurs & Investment Trends in India

Recent Investment and Ecosystem Highlights  India’s biotech startup ecosystem is moving beyond early-stage experimentation into a phase of strategic innovation and scalable commercial ventur...

Saurabh Chaubey
May 14, 2026
Read More
  • Opinions

India’s Push Toward API Self-Reliance 

Latest Developments on API Self-Reliance  India has long been recognized as the “pharmacy of the world,” supplying affordable generic medicines to countries across the globe. However, despite its...

Saurabh Chaubey
May 7, 2026
Read More
1234
The PharmaIndia delivers sharp, credible, and comprehensive insights on the Indian pharmaceutical industry including regulatory updates, market analysis, M&A deals, R&D breakthroughs, policy changes, and innovation trends that drive the sector forward.

Contact Us

Address: 201, Second Floor, H65, Sector 63 Noida, Uttar Pradesh, India 201301

Email: connect@thepharmaindia.in

Phone:  +91 9582 193319

Social Media

Facebook10FansLikeX (Twitter)12FollowersFollowInstagram15FollowersFollowYoutube10SubscribersSubscribe

    Copyright © 2026 All Rights Reserved | The PharmaIndia - An Initiative From PharmaShots